Menu Close

Cost-Effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial

Citation

Gyamfi-Bannerman, Cynthia; Zupancic, John A. F.; Sandoval, Grecio; Grobman, William A.; Blackwell, Sean C.; Tita, Alan T. N.; Reddy, Uma M.; Jain, Lucky; Saade, George R.; & Rouse, Dwight J., et al. (2019). Cost-Effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatrics, 173(5), 462-8. PMCID: PMC6503503

Abstract

IMPORTANCE: Administration of corticosteroids to women at high risk for delivery in the late preterm period (34-36 weeks' gestation) improves short-term neonatal outcomes. The cost implications of this intervention are not known.

URL

http://dx.doi.org/10.1001/jamapediatrics.2019.0032

Reference Type

Journal Article

Journal Title

JAMA Pediatrics

Author(s)

Gyamfi-Bannerman, Cynthia
Zupancic, John A. F.
Sandoval, Grecio
Grobman, William A.
Blackwell, Sean C.
Tita, Alan T. N.
Reddy, Uma M.
Jain, Lucky
Saade, George R.
Rouse, Dwight J.
Iams, Jay D.
Clark, Erin A. S.
Thorp, John M., Jr.
Chien, Edward K.
Peaceman, Alan M.
Gibbs, Ronald S.
Swamy, Geeta K.
Norton, Mary E.
Casey, Brian M.
Caritis, Steve N.
Tolosa, Jorge E.
Sorokin, Yoram
VanDorsten, J. Peter., for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine (MFMU) Units Network

Year Published

2019

Volume Number

173

Issue Number

5

Pages

462-8

PMCID

PMC6503503

Reference ID

13022